Global Monoclonal Antibody Custom Service Market, By Type (Rat Custom Monoclonal Antibody, Rabbit Custom Monoclonal Antibody and Others), By Application (Diagnostic, Therapeutic, protein purification) By End User (Hospital, ASC, Cardiology Center) opportunities and forecast 2020-2027
Monoclonal Antibodies are class of the antibodies derived from single ancestral cell. The antibodies have the tendency to grow indeterminately and are very specific for location in body derived from single clone. Growing investment in R&D, increasing prevalence of the chronic infections, diseases, and rising incidence of immunological diseases are some of the key factors driving market growth. However, high price of the monoclonal antibody services are expected to hinder the growth of the market to some extent.
The service offers development of both mouse and rat hybridomas for production of custom monoclonal antibodies from the recombinant protein antigens or synthesized peptide. The services provide comprehensive services for the antibody cloning, engineering, expression, and purification in addition to the custom antibody development for the multiple biotechnological and pharmaceutical companies.Segment Overview
The global market is segmented based on application, type, and end-users. Based on type, the market is categorized into rabbit custom monoclonal antibody, rat custom monoclonal antibody, and others.
Further, on the basis of application, market is categorised into therapeutic application, diagnostic application, and protein purification. Regional Overview
The North America dominates the market due to the presence of well-developed technology, patient population, the presence of the leading players and high healthcare expenditure. As per the National Cancer Institute (NCI) in 2016, over 1.6 million new cases of cancer were diagnosed in the U.S.
Europe holds second position in market. It is anticipated that support provided by government bodies for R&D drives the market in the European region. Asia-Pacific is likely to be fastest growing during forecast period. The rapid growth is attributed to increasing risk of the infectious diseases in the region. Middle East and Africa (MEA) holds the least share in market due to the presence of slow developing and poor countries, especially, in the African region.Key Players
- Thermo Fisher Scientific
- Abnova Corporation
- Abcam plc
- ProMab Biotechnologies Inc,
- Precision Antibody
- Sino Biological
- Rat Custom Monoclonal Antibody
- Rabbit Custom Monoclonal Antibody
- Diagnostic Application
- Therapeutic Application
- Protein Purification
- North America
- Rest of Europe
- South Korea
- Rest of Asia-Pacific
- Saudi Arabia
- Rest of LAMEA